Success Metrics

Clinical Success Rate

71.4%

Based on 15 completed trials

Completion Rate

71%(15/21)

Active Trials

8(24%)

Results Posted

20%(3 trials)

Terminated

6(18%)

Phase Distribution

Ph early_phase_1

24%

Ph not_applicable

24%

Ph phase_1

24%

Ph phase_2

15%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution29 total trials

Early Phase 1First-in-human

8(27.6%)

Phase 1Safety & dosage

8(27.6%)

Phase 2Efficacy & side effects

5(17.2%)

N/ANon-phased studies

8(27.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

65.2%

15 of 23 finished

Non-Completion Rate

34.8%

8 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(8)

Completed(15)

Terminated(8)

Other(3)

Detailed Status

Completed15

Recruiting7

Terminated6

unknown2

Withdrawn2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 2

Trials by Phase

Early Phase 18 (27.6%)

Phase 18 (27.6%)

Phase 25 (17.2%)

N/A8 (27.6%)

Trials by Status

unknown26%

completed1544%

withdrawn26%

recruiting721%

active_not_recruiting13%

terminated618%

suspended13%

Recent Activity

8 active trials

Showing 5 of 34

terminatedphase_1

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more

NCT03953326Phase 1

HeartPhone Cancer Survivors Trial 2019

Terminated

NCT06520982Early Phase 1

Early Neurovascular Adaptations in Aging Women

Recruiting

NCT06499844Early Phase 1

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

Recruiting

NCT06043310

Estrogen and Microvascular Function

Active Not Recruiting

NCT05193968Not Applicable

Hot Flashes and Neurovascular Function in Women

Recruiting

NCT05653973Early Phase 1

Prenatal Aspirin and Postpartum Vascular Function

Recruiting

NCT05946798Early Phase 1

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Recruiting

NCT05946785Early Phase 1

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Recruiting

NCT04001647Early Phase 1

Targeting ER Stress in Vascular Dysfunction

Terminated

NCT06443151

Role of Endothelial Function in SCI CVD Risk

Recruiting

NCT03446612Phase 2

Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)

Terminated

NCT02987465

Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.

Completed

NCT00453531Phase 1

Model System for Transient Forearm Blood Vessel Dysfunction

Completed

NCT03462017Phase 1

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Completed

NCT03972683Early Phase 1

Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training

Withdrawn

NCT03738943Early Phase 1

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults